128
Participants
Start Date
August 19, 2022
Primary Completion Date
September 30, 2025
Study Completion Date
September 30, 2025
Pitolisant
"Pitolisant 4.45 mg tablets~Pitolisant 17.8 mg tablets"
Northwell Health, New Hyde Park
Abington Neurological Associates, Willow Grove
Respiratory Specialists, Wyomissing
Duke University School of Medicine, Durham
Clinical Research of Gastonia, Gastonia
ARSM Research, Huntersville
Bogan Sleep Consultants, Columbia
Lowcountry Lung Critical Care, North Charleston
Neurotrials Research Inc., Atlanta
Florida Pediatric Research Institute, Winter Park
Meris Clinical Research, Brandon
St. Francis Medical Institute, Clearwater
Neurology Clinic, P.C., Cordova
Ohio Sleep Medicine and Neuroscience Institue, Dublin
North Star Medical Research, Middleburg
NeuroScience Research Center, LLC, Canton
Intrepid Research, LLC, Cincinnati
Clinical Neurophysiology Services, Sterling Heights
Western Michigan University Homer Stryker MD School of Medicine, Kalamazoo
University of Wisconsin-Madison, Madison
NorthShore University Health System, Glenview
OSF HealthCare Saint Francis Medical Center, Peoria
St. Luke's Sleep Medicine and Research Center, Chesterfield
Clayton Sleep Institute, St Louis
Great Plains Health, North Platte
Northwest Houston Neurology and Sleep, Tomball
Comprehensive Sleep Medicine Associates, Sugar Land
Central Texas Neurology Consultants, PA, Round Rock
FutureSearch Trials of Neurology LP, Austin
Cedars-Sinai Medical Towers, Los Angeles
Sleep Medicine Specialists of California, San Ramon
Sleep Dynamics, Neptune City
Harmony Biosciences Management, Inc.
INDUSTRY